Navigation Links
Keck Foundation funds study of biological interactions with nanomaterials
Date:9/11/2007

The University of Oregon has received a $1.6 million grant from the W.M. Keck Foundation to explore the biological effects of exposure to precisely engineered nanoparticles that are being designed for diagnostic and therapeutic uses.

The three-year grant from the Keck Foundations medical research program will involve six researchers: Mark Lonergan, Jim Hutchison and Andy Berglund, all UO professors of chemistry; UO biology professors Karen Guillemin and Eric Johnson; and Robert Tanguay, a professor of environmental and molecular toxicology at Oregon State University.

All are members of the Safer Nanomaterials and Nanomanufacturing Initiative (SNNI), directed by Hutchison and part of the Oregon Nanoscience and Microtechnologies Institute (ONAMI).

This award from the Keck Foundation puts us at the forefront of this quickly developing and promising field of nanotechnology, said UO President Dave Frohnmayer. Nanotechnology has been described as being in its discovery phase. This newly funded project means the University of Oregon, Oregon State University and the state, through ONAMI Oregons first Signature Research Center can help build a green roadmap for the field.

The interdisciplinary project is designed to help researchers understand potential biological interactions of engineered nanomaterials and develop design rules for the development of nanoparticles with enhanced biological properties. The researchers will produce specific structures of nanomaterials, investigate their interactions with biological systems and then design new materials and nanoparticle libraries that have specific biological responses.

The biological testing will involve laboratory experiments using zebrafish, an invertebrate animal model system that was first developed for research at the University of Oregon. With zebrafish, researchers can monitor tissue-specific interactions with nanoparticles, developmental and acute toxicity, and the im
'/>"/>

Contact: Jim Barlow
jebarlow@uoregon.edu
541-346-3481
University of Oregon
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. W.M. Keck Foundation funds study of friendly microbes
2. Digging in the dirt for lifes biochemical foundations
3. Protein folding: Building a strong foundation
4. WHO suspends Marburg work, appeals for new funds
5. Grand Challenges in Global Health initiative funds Yale project
6. European Commission funds EBI to do new research on synergies between bioinformatics and medical informatics
7. Federal grant funds research on novel HIV therapy
8. Bioartificial kidney under study at MCG
9. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
10. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
11. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...open for the Society of Interventional Radiology,s...ies" Webinar, which will provide the latest update...iver tumors, kidney tumor ablation and lung tumor ...ians, scientists and allied health professionals d...ring advances in image-guided therapy. , The Web...
(Date:11/6/2009)... -- Auburn Hills, MI-based Law Enforcement Intelli...cker system and patent-pending Biometric Access Co...Health and Human Services, National Institutes of ...stem will support the NIH,s entire police force th...cal research agency. The project is expected to b...
(Date:11/5/2009)...ale University have developed synthetic molecules ... HIV and HIV-infected cells, as well as to prostat...n the Journal of the American Chemical Society , ...se diseases. , The molecules called "antibody-...tibody-recruiting molecule targeting prostate canc...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Studies show dramatic decline in rheumatoid vasculitis in US veterans 55469 1Studies show dramatic decline in rheumatoid vasculitis in US veterans 55469 2Discovery of natural odors could help develop mosquito repellents 13710 1Discovery of natural odors could help develop mosquito repellents 13710 2Discovery of natural odors could help develop mosquito repellents 13710 3Senator Ted Kennedy 3A A Member of the NAMI Family 55466 1Senator Ted Kennedy 3A A Member of the NAMI Family 55466 2
...ly reside on the skin of healthy people can cause ... researchers at the Swedish medical university Kar...or why a certain kind of staphylococcus can attach...osystems: the bacteria are like tufted, self-adhes...elf on the child,s skin and mucous membranes direc...
... limestone countertop, a practiced eye and Google ... of fossils that may shed light on the origins of ...ous story, featuring University of Michigan paleon... Sanders, is the subject of a segment on the award...ently airing on public television stations (Episod...
...y Sanders today joined UC San Diego Chancellor Mar... to announce their support for a regional partners...gae into biofuels. , Speaking at a news conferenc...hers said the San Diego region, now home to more t...jor center for renewable energy development, as sc...
Other Biology News:Tufted bacteria cause infection in premature babies 2Google Earth aids discovery of early African mammal fossils 2Google Earth aids discovery of early African mammal fossils 3Regional partnership to develop algal biofuels gets backing of San Diego leaders 2Regional partnership to develop algal biofuels gets backing of San Diego leaders 3Regional partnership to develop algal biofuels gets backing of San Diego leaders 4Regional partnership to develop algal biofuels gets backing of San Diego leaders 5Regional partnership to develop algal biofuels gets backing of San Diego leaders 6
(Date:11/9/2009).../ -- NexBio, Inc. announced the presentation of ne...rgy, Asthma, and Immunology in Miami, Florida. Th...), a Sialidase, Decreases Airway Resistance and Ha...s of Asthma". ,, DAS181 (Fludase ® ) is an...g candidate being studied in human clinical develo...
(Date:11/9/2009)...he top 10 pharmaceutical giants use Datafarm for p...ada. Datafarm’s announcement comes on the he...eeting where Health Canada stated that, effective ...CTD regulatory submissions for New Drug Submission...st. , Marlborough, MA (PR...
(Date:11/9/2009)...swire/ -- Following the provision of clinical,and ...tion (FDA), privately,owned UK company Daval Inter...om ) has been informed that its innovative,anti-in...phan-Drug,designation for the treatment of Amyotro... known as Lou Gehrig,s disease, is the most common...
(Date:11/8/2009).... 5, 2009 Complete Genomics, a third-generation h...blication of a report in the journal Science des...ncluding analysis of sequence data from three comp... three genomes sequenced on the proof-of-principle... coverage to $1,726 for 45x coverage for the sampl...
Breaking Biology Technology:NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2
..., , AquaPure Genomic DNA Isolation... yield range: 250 g DNA (15-ml tube prep), ,... 1. Add 1 ml body fluid (e.g., cerebrospinal fl...ovial fluid, urine, whole blood, milk) to a steril... cell lysis solution. Pipet up and down several ti...
..., Andrew Conn, Lindy Durrant, and Ian Spendl...tingham City Hospital, Hucknall Road,Nottingham... , Gene gun immunization through the skin...of DNA vaccine delivery, and has been shown to be ... in animal models to both infectious diseases and ...
..., Jolanta Kolodziejek, MSc, and Professor No...roup, Institute of Virology, University of Veterin...1, A 1210 Vienna, Austria , , ...emplate employed in sequencing PCR (cycle sequenci...eotide sequencing. The presence of , cont...
Other Biology Technology:Genomic DNA Isolation From 1 ml of Body Fluid 2Delivery of pCMV-S DNA Using the Helios Gene Gun System Is Superior to Intramuscular Injection in Balb/c Mice 2Delivery of pCMV-S DNA Using the Helios Gene Gun System Is Superior to Intramuscular Injection in Balb/c Mice 3Delivery of pCMV-S DNA Using the Helios Gene Gun System Is Superior to Intramuscular Injection in Balb/c Mice 4Delivery of pCMV-S DNA Using the Helios Gene Gun System Is Superior to Intramuscular Injection in Balb/c Mice 5Delivery of pCMV-S DNA Using the Helios Gene Gun System Is Superior to Intramuscular Injection in Balb/c Mice 6Delivery of pCMV-S DNA Using the Helios Gene Gun System Is Superior to Intramuscular Injection in Balb/c Mice 7Delivery of pCMV-S DNA Using the Helios Gene Gun System Is Superior to Intramuscular Injection in Balb/c Mice 8Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 2Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 3Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 4
Mouse Anti-Human huntingtin Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
PureLink HiPure Plasmid Filter Midiprep Kit from Invitrogen
ViraPower UbC Lentiviral Gateway Expression Kit from Invitrogen
ViraPower Lentiviral Packaging Mix from Invitrogen
Biology Products: